Neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) are significant drivers of vision loss in the United States, and they put substantial burdens on patients both from the disease itself and the need for regular treatment. Less-frequent injection protocols using newer anti-VEGF agents can reduce treatment burden for patients and their caregivers without compromising efficacy. In this program, expert faculty will review cases that illustrate the possibilities for providing extended treatment intervals for patients with neovascular retinal diseases.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 259 Prospect Plains Rd, Bldg H
Pricing
100% of listed courses are free
265 of 265 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Neurosurgery
- Nuclear Medicine
- Ophthalmology
- Pediatric Hematology-Oncology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Surgical Oncology
- Urological Oncology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedMar 31, 2026
-
Last day to claim creditApr 1, 2027 6 months left
-
Paradigm Medical Communications, LLC The Many Faces of Neovascular Retinal Disease: Individualizing the Use of Sustained Delivery Therapy
-
CME Outfitters, LLC Beyond VEGF: Understanding Blood-Retinal Barrier Biology and Emerging Mechanisms in DME and Neovascular AMD
-
ScientiaCME Looking forward without losing sight: present and emerging management strategies for neovascular age-related macular degeneration
-
Physicians’ Education Resource (CME Track) Rapid Reviews in Retina(TM): 2026 Updates – Episode 1: nAMD
-
Physicians’ Education Resource (CME Track) Rapid Reviews in Retina(TM): Emerging Updates from Winter 2026 – Addressing the Wealth of New Data in Treatments for nAMD, DME and RVO
-
Physicians’ Education Resource (CME Track) Reducing Treatment Burden in Retinal Disease Care With Extended-Duration Anti-VEGF Therapies
